Research Study

A New Approach to an Old Problem: Redesigning Latent Tuberculosis Screening and Treatment

California has the highest incidence and largest number of tuberculosis (TB) cases in the contiguous U.S., of which 80% are due to reactivation. These TB cases can be prevented via screening and treatment of latent tuberculosis infection (LTBI), yet, current adoption of the latent TB screening and treatment guidelines has been extremely poor. We will leverage expansive electronic health record data from two of the largest healthcare organizations in California to create and validate a new LTBI screening and treatment approach that can vastly improve identification and successful treatment of LTBI.

Principal Investigator:

Sara Yee Tartof, PhD, MPH

Funding Source:

National Institute of Allergy and Infectious Diseases (NIAID)

Funding Years:

2020 - 2025

Research Categories: